EFFECT OF IBUPROFEN AND DICLOFENAC ON THE CHEMOTAXIS INDUCED BY SUBSTANCE-P AND TRANSFORMING GROWTH-FACTOR-BETA ON HUMAN MONOCYTES AND POLYMORPHONUCLEAR CELLS

被引:13
作者
LOCATELLI, L [1 ]
SACERDOTE, P [1 ]
MANTEGAZZA, P [1 ]
PANERAI, AE [1 ]
机构
[1] UNIV MILAN, SCH MED, DEPT PHARMACOL, VIA VANVITELLI 32, I-20129 MILAN, ITALY
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1993年 / 15卷 / 07期
关键词
D O I
10.1016/0192-0561(93)90021-P
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The neuropeptide substance P and the cytokine transforming growth factor-beta are potent chemotactic factors for monocytes or polymorphonuclear cells. They are present in synovial fluid of arthritic patients, and participate in the pathogenesis of arthritis. We investigated, in vitro, the effect of two non-steroidal anti-inflammatory drugs, ibuprofen and diclofenac, on the chemotactic effect of substance P and transforming growth factor-beta at concentrations that can be present in the synovial fluid of arthritic patients. Both drugs decrease the chemotaxis induced by substance P and transforming growth factor-beta, at concentrations that can be easily reached in the synovial fluid during therapy. This event could be involved in the effect of some non-steroidal anti-inflammatory drugs on the development and progress of arthritic disease.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 17 条
  • [1] NONSTEROIDAL ANTIINFLAMMATORY DRUGS EXERT DIFFERENTIAL-EFFECTS ON NEUTROPHIL FUNCTION AND PLASMA-MEMBRANE VISCOSITY - STUDIES IN HUMAN NEUTROPHILS AND LIPOSOMES
    ABRAMSON, SB
    CHERKSEY, B
    GUDE, D
    LESZCZYNSKAPIZIAK, J
    PHILIPS, MR
    BLAU, L
    WEISSMANN, G
    [J]. INFLAMMATION, 1990, 14 (01) : 11 - 30
  • [2] ADAMS DH, 1991, J IMMUNOL, V147, P609
  • [3] DEVILLIER P, 1986, NEW ENGL J MED, V314, P1323
  • [4] PLASMA AND SYNOVIAL-FLUID CONCENTRATIONS OF DICLOFENAC SODIUM AND ITS HYDROXYLATED METABOLITES DURING ONCE-DAILY ADMINISTRATION OF A 100 MG SLOW-RELEASE FORMULATION
    FOWLER, PD
    DAWES, PT
    JOHN, VA
    SHOTTON, PA
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) : 469 - 472
  • [5] HENDERSON B, 1987, BR MED B, V41, P418
  • [6] IP M, 1990, BRIT J RHEUMATOL, V29, P363
  • [7] LAFYATIS R, 1989, J IMMUNOL, V143, P1142
  • [8] LOTZ M, 1985, SCIENCE, V2355, P893
  • [9] MARSHALL KW, 1990, ARTHRITIS RHEUM, V33, P87
  • [10] MCGILLIS JP, 1990, ANN NY ACAD SCI, V594, P85